PubMed

The history of state preemption and medical device regulation: lessons for artificial intelligence oversight.

PMID: 41815749 · 2026-03-03

C, a, s, e, , T, h, o, m, a, s, o, n, ;, , L, a, r, r, y, , B, u, c, s, h, o, n, ;, , B, r, i, a, n, , J, , M, i, l, l, e, r, ;, , B, r, i, a, n, , Y, a, g, i

ЖурналHealth affairs scholar

Год2026-03-03

PMID41815749

Аннотация

Rapid expansion of artificial intelligence (AI) in health care has outpaced the United States' fragmented regulatory structure, which currently relies on overlapping albeit incomplete federal oversight from multiple agencies. In the absence of clear federal product standards, some states have advanced broad and inconsistent regulatory schemes that often sweep AI-enabled medical devices into consumer-protection frameworks not designed for clinically used technologies. These state-level requiremen

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.